Clinical trial
Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic…
NCT00079170 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00079170 |
|---|---|
| Title | Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer |
| Official title | A Pilot Study to Evaluate the Influence of Garlic on the Pharmacokinetics of Docetaxel in Patients With Metastatic Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | garlic, docetaxel |
| Start date | Jan 1, 2004 |
| Completion | Oct 1, 2007 |
| First posted | Mar 10, 2004 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: